Lars Kongsbak

Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark.

Samplix ApS provides technology for enrichment of deoxyribonucleic acid samples. Its PINS technology enables enrichment of deoxyribonucleic acid or ribonucleic acid targets from extremely complex and low abundance samples such as environment, blood, or biopsy samples. The company was founded in 2013 and is headquartered in Herlev, Denmark.

Bluebee Holding BV engages in the development of a private cloud-based accelerated genomics platform. It supports cross-functional teams of life science researchers and clinicians by effectively centralizing and managing their genomics data processes and storage needs. The company was founded in 2011 by Vlad-Mihai Sima, Koen Bertls, Luk Wayne, and Zaid Al-Ars and is headquartered in Rijswijk, the Netherlands.